Selank on TikTok: separating real research from peptide hype

What did @thenurseinjectorhana actually say?

The creator, who identifies as a nurse injector, says selank has "truly changed my life" and that she has "an extremely anxious brain." She describes the peptide as doing "a really good job keeping my nervous system in check." She also points viewers toward a vendor, noting they offer starter kits and publish certificates of analysis (COAs) on their website. That last point is worth separating from the anxiety claim, because one is a regulatory detail and the other is a health claim with real stakes.

To be clear: she is not claiming selank cures an anxiety disorder. She is sharing a personal experience. But on TikTok, personal testimonials from people with clinical titles carry outsized weight, and 21,800 views means a lot of people heard a nurse say this peptide fixed her nervous system. That context matters for how we evaluate what she said.

Does the science back this up?

There is legitimate preclinical and limited clinical research on selank, but calling it robust would be a stretch. Most of what exists comes from Russian research institutions, which raises replication concerns. The anxiolytic signal is real in animal models, but human trial data is thin.

Selank is a synthetic analog of tuftsin, a naturally occurring immunomodulatory peptide. Russian studies, including work by Seredenin and Gudasheva published across several years in journals like Eksperimental'naya i Klinicheskaya Farmakologiya, found anxiolytic effects in rodent models and some early human trials involving generalized anxiety disorder. A 2014 study by Zozulya et al. in Bulletin of Experimental Biology and Medicine reported reduced anxiety scores in patients compared to phenazepam, a Russian benzodiazepine. That sounds promising until you notice the sample sizes were small, the trials were not placebo-controlled in most cases, and none of this has been replicated in large, independent, Western clinical trials. The mechanism proposed involves modulation of GABA-A receptors and BDNF expression, which is biologically plausible. Plausible is not the same as proven.

What did they get wrong (or right)?

She got the vendor transparency point right. COAs matter. If a company selling research peptides publishes third-party certificates of analysis, that is a meaningful quality signal, and most do not bother. Credit where it is due.

Where she oversells is in the certainty of the personal claim. Saying selank "keeps my nervous system in check" positions it as a reliable, understood intervention. The placebo effect in anxiety research is notoriously strong. Without a controlled comparison, a self-report from anyone, nurse or not, cannot tell us whether the peptide is doing the work or the ritual of taking it is. That is not a personal attack; it is just how evidence works.

She also sends viewers to a vendor via Linktree with affiliate-style framing. Recommending specific commercial sources for unregulated research compounds, especially to "first time peppers," without disclosing financial relationships or noting that selank is not FDA-approved for any indication is a gap that deserves naming. Selank is sold legally in the US only as a research chemical, not for human use.

What should you actually know?

If you are curious about selank, here is what the honest picture looks like. The anxiolytic research is interesting but early. The best available human data comes from small Russian trials with methodological limitations. There are no FDA-approved uses. There are no established dosing guidelines validated in large populations. The peptide is sold as a research compound, meaning quality control depends entirely on the vendor, which is exactly why COAs matter and why the creator's point about transparency is not nothing.

People with anxiety disorders should also know that self-treating with unregulated peptides instead of pursuing evaluated options, therapy, SSRIs, buspirone, and others with decades of safety data, carries real risk. Not necessarily catastrophic risk with selank specifically, but the risk of delaying effective treatment and the risk of sourcing a compound that is not what the label says. If you are working with a licensed provider who has reviewed your history, that is a different conversation. If you are a first-timer buying from a Linktree recommendation, that is not the same thing.